Bloomberg

New Summary: 8.10.18

Submitted by hm_admin on Fri, 08/10/2018 - 18:50

HHS: HHS allows Medicare price negotiations based on Trump Administration proposal: “By allowing Medicare Advantage plans to negotiate for physician-administered drugs like private-sector insurers already do, we can drive down prices for some of the most expensive drugs seniors use.” The change only applies to Medicare Part B and will affect the more than 20 million Americans enrolled in Medicare Advantage plans.

The Hill: New HHS Medicare price negotiation policy faces opposition: Patient groups and drug makers are against the drug price policy announced this week, which gives certain insurers the ability to require patients to try cheaper drugs before the more expensive options. “This policy, instead of really getting at the heart of the matter of lowering high drug prices, is putting up more barriers between patients and the drugs they need to stay healthy and live.”